retatrutide ly3437943 parkinson's disease clinical trial therapies in the pipeline: a 10-year retrospective analysis Retatrutide Results: 28.3% Weight Loss

From the first week, I've felt a significant decrease in evening cravings, which have been a challenge for me

Lemme isnt a GLP-1 clinic, but for people comparing weight-loss options, it makes sense to look at how it measures up against prescription programs: Swipe to scroll the table below Wait

There were 17 NAION events in the GLP-1 group compared to 6 in the non-GLP-1 RA group

The GLP-1 consumer over-indexes on food and beverage at about 9% higher than the non-user. Circana data shows 5.3% of consumers are actively embracing GLP-1s, and the number may rise to double-digits for those who have at least tried the drug, according to Lyons Wyatt

N Engl J Med, 2023

If you choose 18:6, protein tracking becomes non-negotiable